• Profile
Close

Use of gabapentin in posterior spinal fusion is associated with decreased postoperative pain and opioid use in children and adolescents

Journal of Spinal Disorders & Techniques Jun 06, 2019

Trzcinski S, et al. - In this retrospective cohort study of 129 children aged 10 to 21 years undergoing posterior spinal fusion (PSF) for adolescent idiopathic scoliosis, researchers examined how gabapentin use associates with inpatient postoperative daily pain scores and opioid use in these children. They defined adjuvant gabapentin exposure as at least 15 mg/kg/d by postoperative day 1 with an initial loading dose of 10 mg/kg on the day of surgery. Outcomes revealed improved pain scores and decreased opioid use in the first 48 to 72 hours postoperatively in correlation to adding gabapentin as adjuvant therapy for adolescent PSF, beginning on day of surgery.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay